HSP90AB1 and neoplasm: This control is lost in tumours harbouring a mutant p53 which exhibit a dramatic, constitutive hyperstabilization of p53—both mutant and wild type forms—due to a stable complex between Hsp90 and the mutant p53 inhibiting Mdm2 and CHIP [94].